Effects of pemafibrate (a selective PPAR-¿ agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLD Kanako Kato; Teruo Jojima; Dai Tanuma; Kanako Suda; Shintaro Sakurai; Toshie Iijima; Takuya Tomaru; Isao Usui; Yoshimasa Aso;

Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients? Taisa Grotta Ragazzo; Patricia Momoyo Yoshimura Zitelli; Daniel F. Mazo; Claudia P. Oliveira; Flait José Carrilho; Mário Guimarães Pessoa;

Diabetes influences liver stiffness in chronic hepatitis C patients with and without virological cure: A longitudinal study Daniela Malta Pontual; Leticia Cancella Nabuco; Ronir Raggio Luiz; Ana Carolina Cardoso; Renata M. Perez; Cristiane A. Villela-Nogueira;